Vertex Pharmaceuticals Incorporated Earnings

Vertex Pharmaceuticals Incorporated’s revenue jumped 10.99% since last year same period to $3076.4Mn in the Q3 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 3.77% jump in its revenue since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit jumped 3.59% since last year same period to $1082.9Mn in the Q3 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 4.84% jump in its net profits since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit margin fell -6.67% since last year same period to 35.2% in the Q3 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 1.03% jump in its net profit margins since last 3-months.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 4.61 - a 23.92% jump from last quarter’s estimates.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 4.61.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Vertex Pharmaceuticals Incorporated has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.